|
|
Volumn 20, Issue 11, 1997, Pages 1791-1792
|
|
American Diabetes Association Annual Meeting, 1997: Type 2 diabetes
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1,1 DIMETHYL 2 (2 MORPHOLINOPHENYL)GUANIDINE FUMARATE;
2 [(4 CHLOROPHENOXY)METHYL] 7A (3,4 DICHLOROPHENYL)TETRAHYDROPYRROLO[2,1 B]OXAZOL 5(6H) ONE;
ACARBOSE;
CHLORPROPAMIDE;
CHROMIUM PICOLINATE;
GLIBENCLAMIDE;
GLIPIZIDE;
INSULIN;
METFORMIN;
MIGLITOL;
NATEGLINIDE;
ORAL ANTIDIABETIC AGENT;
REPAGLINIDE;
SULFONYLUREA DERIVATIVE;
TROGLITAZONE;
UNCLASSIFIED DRUG;
CLINICAL TRIAL;
COST OF ILLNESS;
DIARRHEA;
DIET THERAPY;
EDEMA;
FLATULENCE;
HUMAN;
INSULIN RESISTANCE;
MEDICAL RESEARCH;
MEDICAL SOCIETY;
MINERAL INTAKE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
ORAL DRUG ADMINISTRATION;
PREDICTION;
REVIEW;
VERTIGO;
|
|
EID: 0030832951
PISSN: 01495992
EISSN: None
Source Type: Journal
DOI: 10.2337/diacare.20.11.1791 Document Type: Review |
|
Times cited : (8)
|
|
References (0)
|